# Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes

> **NCT00694278** · — · UNKNOWN · sponsor: **Ferzli, George S., M.D. F.A.C.S.** · enrollment: 15 (estimated)

## Conditions studied

- Type II Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00694278
- **Lead sponsor:** Ferzli, George S., M.D. F.A.C.S.
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2008-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694278, "Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00694278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*